Study design
CVDs
CARDIOVASCULAR DISEASES
This pragmatic, parallel-group, non-inferiority, pilot quasi-randomised controlled trial was conducted from September 2020 to April 2022, and 40 patients with cardiovascular diseases (CVDs) were shortlisted. Initially, hospital-based CR was performed for 4 weeks for all participants. Then, quasi-randomised allocation was performed, followed by 12 weeks of remote or hospital-based CR. Intergroup comparisons were performed. The differences between the two groups were evaluated. In addition, each group underwent baseline and 12-week assessments for each comparison. Patients were excluded from the study if any exclusion criterion was met during the 4-week hospital CR and cardiopulmonary stress test.Hospital-based CR and remote CR exercises were based on the American College of Sports Medicine [